| |
|
|
|
Seres Theraptc  
|
|
24.715 -0.685 (-0.03%) |
01-21 11:47 |
|
Open: |
25.63 |
Pre close: |
25.4 |
Target:
|
31.30
|
|
High: |
25.85 |
Low: |
23.8 |
Resistance:
|
26.80
29.23
|
|
Volume: |
432,213 |
Market Cap: |
2255M |
Support:
|
22.87
19.03
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
25.20
 |
MACD |
MACD(12,26):
|
-0.37 |
|
MA(20): |
25.45 |
Signal(12,26,9): |
-0.37  |
|
MA(100): |
28.07 |
Stochastic Oscillator |
%K(14,3):
|
29.41 |
|
MA(250): |
14.83 |
%D(3): |
33.88 |
|
Average Volume(K) |
3-Month: |
100913
|
52-Week |
High:
|
38.50 |
|
10-Days: |
104637 |
Low: |
2.52 |
|
RSI |
RSI(14):
|
44.25 |
Change(%): |
680.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.200 |
Return on Equity (ttm) |
-115.1 |
Shares Out. (M) |
91.25 |
|
EPS Est. Current Year |
-2.510 |
Return on Assets (ttm) |
-23.3 |
Shares Float (M) |
63.27 |
|
EPS Est. Next Year |
-2.860 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.26 |
|
EPS Est. Next Quarter |
-0.780 |
Qtrly Rev. Growth |
-79.8 |
% Held by Institutions |
81.20 |
|
Forward EPS |
-1.240 |
Gross Profit (p.s.) |
-0.500 |
Shares Short (K) |
4540 |
|
Book Value (p.s.) |
2.060 |
EBITDA (p.s.) |
-0.905 |
P/E |
-20.37 |
|
Sales Per Share |
0.255 |
Qtrly Earnings Growth |
0.00 |
P/BV |
11.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-89.73 |
P/S |
95.84 |
|
Operating Margin |
-384.24 |
Levered Free Cash Flow
(M) |
-44.07 |
P/CF |
-24.85 |
|
|
|
|
|
|
